Olaparib
This page contains brief information about olaparib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Lynparza
FDA Approved
Yes
Use in Cancer
Olaparib is approved to treat:
- Ovarian cancer that is advanced. It is used in patients whose cancer has certain mutations in the BRCA1 and BRCA2 genes and who have already been treated with at least three other types of chemotherapy.
Olaparib is also being studied in the treatment of other types of cancer.
More About Olaparib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Olaparib - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Targeted Cancer Therapies - Information about the use of this drug to treat cancer.
Research Results
Clinical Trial Analysis Suggests Drug Combination May be Highly Effective in Recurrent Ovarian Cancer - Information from the NCI Press Office about this drug.
NIH Study Uncovers New Mechanism of Action for Class of Chemotherapy Drugs - Information from the NCI Press Office about this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Olaparib - Check for trials from NCI's list of cancer clinical trials now accepting patients.
No hay comentarios:
Publicar un comentario